FDA Approved Products
1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
MONOFERRIC
ferric derisomaltose
Peak
Pharmacosmos
INTRAVENOUS · SOLUTION
iron deficiency anemia in adult patients:
2020
NDA0/100
MORPHINE SULFATE
morphine sulfate
Peak
Fresenius Kabi
INTRAMUSCULAR, INTRAVENOUS · SOLUTION
pain severe enough to require an opioid analgesicfor which alternative treatments are inadequate
2013
NDA0/100
MOUNJARO
tirzepatide
Peak
Eli Lilly and Company
SUBCUTANEOUS · SOLUTION
2022
PeptideNDA0/100
MOUNJARO (AUTOINJECTOR)
tirzepatide
Peak
Eli Lilly and Company
SUBCUTANEOUS · SOLUTION
2022
PeptideNDA0/100
MOUNJARO KWIKPEN
tirzepatide
Peak
Eli Lilly and Company
SUBCUTANEOUS · SOLUTION
2022
PeptideNDA0/100
MOVANTIK
naloxegol oxalate
Peak
ORAL · TABLET
opioid-induced constipation (OIC) in adult patients with chronic non-cancer painincluding patients with chronic pain related to prior cancer+1
2014
NDA0/100
MULPLETA
lusutrombopag
Peak
ORAL · TABLET
thrombocytopenia in adult patients with chronic liver disease
2018
NDA0/100
MULTAQ
dronedarone
Peak
Sanofi
ORAL · TABLET
hospitalization for atrial fibrillation (AF) in patients in sinus rhythm with a history of paroxysmalpersistent AF (
2009
NDA0/100
MULTRYS
trace elements injection 4
Peak
INTRAVENOUS · SOLUTION
coppermanganese+4
2020
NDA0/100
MYCAPSSA
octreotide
Peak
Chiesi
ORAL · CAPSULE, DELAYED RELEASE
2020
PeptideNDA0/100
MYFEMBREE
relugolix, estradiol hemihydrate, and norethindrone acetate
Peak
Sumitomo Dainippon Pharma
ORAL · TABLET
2021
NDA0/100
MYRBETRIQ GRANULES
mirabegron
Peak
ORAL · FOR SUSPENSION, EXTENDED RELEASE
2021
NDA0/100
MYTESI
crofelemer
Peak
ORAL · TABLET, DELAYED RELEASE
2012
NDA0/100
NAFTIN
naftifine hydrochloride
Peak
Enterprise Therapeutics
TOPICAL · GEL
interdigital tinea pedis caused by the organisms Trichophyton rubrumTrichophyton mentagrophytes+1
2013
NDA0/100
NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
naloxone hydrochloride
Peak
INTRAMUSCULAR, SUBCUTANEOUS · SOLUTION
depression
2022
NDA0/100
NATESTO
testosterone
Peak
NASAL · GEL, METERED
2014
NDA0/100
NATROBA
spinosad
Peak
Cipher Pharmaceuticals
TOPICAL · SUSPENSION
2011
NDA0/100
NEOPROFEN
ibuprofen lysine
Peak
Recordati
INTRAVENOUS · INJECTABLE
2006
NDA0/100
NERLYNX
neratinib
Peak
Puma Biotechnology
ORAL · TABLET
metastatic HER2-positive breast cancerbreast cancer
2017
SMNDA0/100
NETSPOT
68ga-dotatate
Peak
INTRAVENOUS · POWDER
2016
NDA0/100
NEUPRO
rotigotine
Peak
UCB Pharma
TRANSDERMAL · FILM, EXTENDED RELEASE
2007
NDA0/100
NEURACEQ
florbetaben f 18
Peak
Molecular Devices
INTRAVENOUS · SOLUTION
2014
NDA0/100
NEXICLON XR
clonidine
Peak
Athena Bioscience
ORAL · TABLET, EXTENDED RELEASE
2009
NDA0/100
NEXLETOL
bempedoic acid
Peak
ORAL · TABLET
2020
NDA0/100